ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,018.39
      -0.34%
      US Tech 100
      16,952.00
      -0.19%
      Dow Jones
      37,903.29
      0.23%
      Brent Oil
      83.565
      0.03%
      Bitcoin
      57,770.55
      -0.81%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. HUTCHMED China Limited (HCM)

      7. HUTCHMED China Limited (HCM) News

      HCM HUTCHMED China Limited

      18.76
      0.25 (1.35%)
      May 01 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      HUTCHMED China Limited HCM NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.25 1.35% 18.76 17:16:11
      Open Price Low Price High Price Close Price Prev Close
      18.31 18.31 18.96 18.76 18.51
      more quote information »

      Recent News

      Date Time Source Heading
      4/26/202408:30GLOBEHUTCHMED Announces Positive CHMP Opinion for Fruquintinib in..
      4/05/202404:30GLOBEHUTCHMED Highlights Data to be Presented at..
      4/02/202400:30GLOBEHUTCHMED and Innovent Jointly Announce NDA Acceptance in..
      3/27/202420:00GLOBEHUTCHMED Announces Savolitinib sNDA Accepted in China for..
      3/21/202420:00GLOBEHUTCHMED Initiates Registration Stage of the ESLIM-02 Phase..
      3/05/202406:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/28/202406:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/28/202406:40EDGAR2Form 20-F - Annual and transition report of foreign private..
      2/28/202406:30GLOBEHUTCHMED Reports 2023 Full Year Results and Provides..
      2/07/202406:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/06/202419:00GLOBEHUTCHMED Highlights Presentation of Phase III Data on..
      2/02/202406:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/02/202403:30GLOBEHUTCHMED Announces that Inmagene Exercises Option to License..
      2/01/202406:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/01/202403:30GLOBEHUTCHMED to Announce 2023 Final Results
      1/30/202406:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/29/202423:53GLOBEHUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval..
      1/11/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/11/202402:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
      1/10/202419:00GLOBEHUTCHMED Announces NDA Acceptance in China for Sovleplenib..
      12/29/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/21/202306:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/13/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/13/202302:00RNSNONHutchmed (China) Limited Completed Enrollment of Phase..
      12/12/202323:30GLOBEHUTCHMED Announces Continued Inclusion of ELUNATE®..
      12/12/202319:00GLOBEHUTCHMED Announces that it has Completed Enrollment of a..
      12/07/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/01/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/01/202302:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
      11/30/202319:00GLOBEHUTCHMED Highlights Clinical Data to be Presented at 2023..
      11/30/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/10/202308:35GLOBEDeutsche Bank ADR Investor Conference: Presentations Now..
      11/09/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/08/202319:11GLOBEHUTCHMED Announces that Takeda Receives U.S. FDA Approval of..
      11/01/202308:35GLOBEInternational companies to host live webcasts at Deutsche..
      10/24/202306:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/16/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/16/202304:30GLOBEHUTCHMED Highlights Clinical Data to be Presented at..
      9/29/202306:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/29/202304:30GLOBEHUTCHMED Announces Submission of New Drug Application for..
      9/14/202306:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/12/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/12/202304:30GLOBEHUTCHMED Highlights Presentation of Results from the Phase..
      9/12/202302:00RNSNONHutchmed (China) Limited Patient Enrollment Completed for..
      9/11/202320:00GLOBEHUTCHMED Completes Patient Enrollment of a Bridging Study of..
      8/31/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/29/202306:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/29/202302:00RNSNONHutchmed (China) Limited BTD in China for Savolitinib for..
      8/28/202320:00GLOBEHUTCHMED Receives Breakthrough Therapy Designation in China..
      8/21/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

      Your Recent History

      NASDAQ
      HCM
      HUTCHMED China
      Delayed Upgrade Clock